EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer.
Cui H, Yu Q, Xu Q, Lin C, Zhang L, Ye W, Yang Y, Tian S, Zhou Y, Sun R, Meng Y, Yao N, Wang H, Cao F, Liu M, Ma J, Liao C, Sun R.
Cui H, et al. Among authors: tian s.
Front Oncol. 2024 Nov 27;14:1433033. doi: 10.3389/fonc.2024.1433033. eCollection 2024.
Front Oncol. 2024.
PMID: 39664199
Free PMC article.